SlideShare a Scribd company logo
1 of 10
Download to read offline
Finnacle Investments
January, 2015
1
Finnacle Investments
In this Issue:
Monthly Portfolio Analysis
Stock Recommendation:
ALEMBIC
PHARMACEUTICALS LTD
Investor Watch: Bill Ackman
What's Hot? (News and
happenings)
Deal Watch
Technical trading term of the
day: Head and Shoulders
Article: Trends Analysis and
Business Opportunities in
BRIC Economies
Return Plus +
(Investments, portfolio and much more)
Banking
26%
Technology
13%
Oil and Gas
8%
Automotive
15%
Pharmaceuticals
13%
Engineering
14%
Media &
Entertainment
8%
Others
3%
Portfolio Allocation as on 31st Dec 2014
Stock Buy Price
(INR)
Sell Price (INR) Holding Period
Return
Infosys 1930 2100 8.81%
Yes Bank 598 763.2 27.63%
PVR 612 685 11.93%
HCL
Technologies
1500 1665.4 11.03%
Akzo Nobel 1320 1450 9.85%
MONTHLY PORTFOLIO ANALYSIS
Finnacle Investments
January, 2015
2
 Alembic Pharma is a leader in several sub-segments of anti-infective therapeutic
segment. In the last two to three years the company has invested heavily in increasing
revenue from chronic therapies and regulated markets, which are high margin businesses.
 The company continues to improve its year-on-year margins year after year with an
EBITDA margin of 19% by the end of FY14. This is expected to grow by 100-125 bps
annually and reach 23-24% over next 3-4 years owing to growing international generic
business on account of: annual launches of 7-9 products in the US market including
complex generics and many high value launches, market share improvement in existing
products in US, ramp up in European generic portfolio where the company is expected to
be the generic for a niche product.
 The company is expected to go live with its own front end in US in FY16 which will
assist in gaining higher market share in the new launches and ramp up existing products
that the company has launched through front end partners.
 Alembic Pharma has final ANDA (Abbreviated New Drug Application) approvals for 31
products out of which it has commercialized 25 products and is expected to launch some
of the products once it has its own front end.
Parameter Value(INR)
52-Week High 493.90 (12-Jan-2015)
52-Week Low 211.25 (27-Jan-2014)
Current Market Price 477.85 (25-Jan-2015)
STOCK RECOMMENDATION: ALEMBIC PHARMACEUTICALS LTD
FUNDAMENTALS
Finnacle Investments
January, 2015
3
 Domestic formulation is expected to grow by 16-18% annually on account of around 25
new launches in specialty segment while international brands (ROW – 3% of sales) are
expected to grow by 25-30% on account of low base and commercialization of products
in new markets like South East Asia, CIS, brazil, East Africa where company has made
filings over last 2 years.
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
Revenue EBITDA PAT
14,679
2,194
1,301
15,260
2,520 1,652
18,684
3,577
2,355
Revenue, EBITDA, PAT (in INR million)
FY12
FY13
FY14
FINANCIAL SNAPSHOT
Finnacle Investments
January, 2015
4
Founder, Pershing Square Capital Management
Ackman got his start in the real estate business, where he worked for his father prior to starting
Gotham. Bill Ackman is an activist investor. He buys the common stocks of public companies,
and pushes for changes so that the market can realize the value of the companies. Ackman buys
stocks trading at a discount, and sells when the companies reach their appraised value. His firm
performed incredibly in 2014. In the first six months of the year, the flagship hedge fund
returned 25% after fees. The portfolio includes new investment in Allergan, which drive
performance. Ackman helped back Valeant Pharmaceuticals' hostile takeover of Allergan by
taking a position in the target company before the effort was made public, benefiting from the
surge in Allergan's stock. In 2014, Ackman has also seen his huge bet against Herbalife go his
way as shares of the company fell. Ackman continues to be one of the most prominent activist
investors, managing some $15 billion and working to raise billions of dollars more in permanent
capital.
INVESTOR WATCH: Bill Ackman
Net Worth: US$1.69 billion (as on
November 2014)
Source of Wealth: Hedge funds, Self-Made
Age: 48
Education: Bachelor of Arts / Science,
Harvard University; Master of Business
Administration, Harvard University
Residence: New York
Finnacle Investments
January, 2015
5
RBI’s surprise rate cut
The Reserve Bank of India (RBI) surprised
markets with a 25 basis point reduction in
repo rates on Thursday, 15 Jan bringing it to
7.75% the Cash reserve ratio is however
remains unchanged to 4%. The main reason
for rate cut is to ease inflationary pressures
and to achieve fiscal deficit target. This
move of RBI will boost investor sentiments
and will have positive impact on capital
intensive industry like Auto and Auto
Ancillary Sector, Real Estate and
Infrastructure sector and Banking and NBFC
sector.
TCS ends RIL's 23-year run as most
profitable firm
Tata Consultancy Services (TCS) has
overtaken Reliance Industries Ltd (RIL) to
become the country's most profitable private
company on a quarterly basis. RIL has
been topping the profitability charts since
1992-93, when it went past Tata Steel in the
rankings. TCS posted a profit of Rs 5328
crore for the quarter ended December where
reliance profit dipped to Rs 5256 crore due
to falling crude oil prices.
Airtel, Idea, RComm & Vodafone may
collectively bid Rs 74,000 crore for 900 Hz
spectrum
Airtel, Idea, RComm & Vodafone may
collectively bid Rs 74,000 crore for
spectrum as these companies are expected to
prioritize 900 MHz airwave renewals over
boosting their 3G . The operators are likely
to factor in existing debt, incremental capex
needs for data business and fallback cash
reserves to acquire super-efficient 4G
airwaves in the 700 MHz band in the near
future spectrum holdings.
Novartis AG and GlaxoSmithKline to
create a global healthcare joint venture
Novartis India is selling its OTC division to
GlaxoSmithKline, Consumer Private Ltd, a
consumer healthcare joint venture between
Novartis AG and GSK, for a consideration
of Rs 109.7 crore. The transfer of the
business is subject to the receipt of all
applicable legal and regulatory approvals,
consents, permissions and sanctions as may
be necessary from concerned authorities.
Drop in the crude oil by 60% since Jan
2014
Crude oil prices have fallen down to its
lowest level of five and a half years. This
drop has been due to increase in the
production of US shale oil and decrease in
demand by Europe and Asia. As per the
Goldman Sachs, WTI will be trading at $41
a barrel and Brent at $42 in three months
and they also believe prices will stay lower
for longer. In order to re-balance the global
market the investment in shale has to be
curtailed. Societal General has reduced their
average WTI price to $51a barrel for this
year and Brent will average around $55 a
barrel. With the supply staying at its own
place and the demand going weak, the oil
prices will keep going down.
What's Hot? (News and Happenings)
Finnacle Investments
January, 2015
6
Apollo Health acquires Nova Specialty Hospital for Rs. 145 crore
In a strategic move aimed at expansion, Apollo Health and Lifestyle, a wholly owned subsidiary
of Apollo Hospitals Group has acquired Nova Specialty Hospital in a Rs. 145 crore deal. Nova is
currently present in 8 cities including Mumbai, Jaipur and Kanpur. The existing Nova centers
will function under the Apollo brand name. Apollo Hospital is looking for a business of Rs.500
crore in a span of 5 years in multi-specialty short stay/day surgery centers, while the combined
network is expected to clock a turnover between Rs 115 crore - 125 crore for the year ending in
Mar'15 and reach break even in the next 18-24 months.
Reliance Capital all set to exit Yatra.com with a 12-fold gain by sale of its 16% stake
Reliance Capital is all set to sell its 16% stake in the online travel portal Yatra.com for Rs 500
crore, a 12-times appreciation since investment of Rs. 40 crore in 2006. The move to exit
Yatra.com cashes in on the booming e-commerce industry and is in sync with the Reliance
Group's recently announced plans to focus on core business and encashing its minority
investments. The company is in talks with 2-3 international investors and expects to close the
deal in 4-6 weeks.
Zomato buys Italian restaurant search guide, its fifth deal on the global front in recent
months
In what would be its fifth buy in the recent months, Zomato Media Private Limited has bought an
Italian restaurant search guide, Cibando for an undisclosed amount. With this, the company has
expanded its presence to 20 countries. The company appears to be on a global acquisition spree
with plans to enter the US market through acquisition of market leaders and building global
payment systems for the diners. Here's a look at Zomato's recent buys:
Company Country Amount
Gastronauci Poland Undisclosed
Lunchtime.cz Czech Republic $2.2 million
Obedovat.sk Slovakia $1 million
MenuMania New Zealand Undisclosed
American Tower Corporation to Pick up Majority Stake in Viom Networks
American Tower Corporation is soon going to acquire 51% stake in Viom networks, the second
largest tower company in India, in a deal that is estimated to be around $ 1 billion. In the first
phase, Srei Infrastructure, which currently holds 18.5% stake would exit the venture while Tata's
current stake of 55% would be trimmed down to 26-30% and would become a minority
DEAL WATCH
Finnacle Investments
January, 2015
7
shareholder along with Macquarie Fund, SBI, GIC, Oman Investment Fund and IDFC. The
second phase of the deal involves merger of Viom with the Indian entity of the ATC which
currently owns 12,000 towers in the country. The merged entity would be looking at a public
offering through which Tatas would seek a complete exit. Viom owns around 42,000 towers in
the country and counts Tata Teleservices as one of its major clients bringing in over 40% of the
revenues. ATC recently acquired 4,800 communication towers from Bharti Airtel for $1.05
billion.
Head and Shoulders pattern is basically identified when the security prices cover all of the
following characteristics:
1. Price first falls to a trough and then make a rise
2. Price again fall below the former trough
3. It makes a rise again.
4. Finally, after this price falls again, but not as far as second trough.
5. Once the final trough, price heads upward towards the resistance level.
INVESTOR DECISION: Investor takes a long position when price rises above the resistance
of the neckline.
First and third troughs are called as shoulder (as shown in figure) and second peak is the
head. We also have inverse Head and Shoulders pattern.
TECHNICAL TRADING TERM OF THE MONTH - HEAD AND SHOULDERS
Finnacle Investments
January, 2015
8
Ageing World
 World is taking a transition in demographics. Population is getting older due to a
combination of longer life expectancy especially in developed markets and decline in
birth rates. Euro-monitor report reveals that in 2012, 577 million people were in the
age category of 65+. This will rise to 775 million people in 2020 and will further rise to
35% in 2050 (keeping in mind current trends).
 Though the demographic shift is more prevalent in developed market- Western
Europe’s median age population is 40, while the global median age is 30. Few
emerging markets like India and China will have significant elderly consumers.
Technology: Niche Opportunities
 One of the game changer points is rise in ownership of technology. Like in 2001,
average spending on computers was US $ 22 in Western Europe and at US $17 in
North America. Now, it has risen to US $ 77 in Western Europe and US $ 73 in
North America.
 Technology aimed at formation of cleaning products that are less likely to use water and
other fossil fuel. The innovations are likely to be game changer in home care.
Income level
 In BRIC mega-cities, exponential economic growth, improvement in living standards and
higher consumer spending will lead to intense competition and market saturation. The
rising disposable income in second tier cities will lead to accessibility of Western brands.
Though smaller in size, BRIC cities have projected to rise up 30-50% in next decades.
Energy efficiency preference
 For energy exporters like Saudi Arabia, UAE; energy affordability and security was
never been the major concern. However, these countries still suffer from impact on
the environment from energy production. For emerging market economies
diversification of energy mix has always been the cause of concern. These countries rely
on fossils for the electricity production. Economic growth and population will raise the
demand for energy in these EMEs.
 In all these 25 economies, aggregate population will expand by around 12.7% during
2014-30 and this will further rise by approximately 10% in 50s. Till 2030, population
in these EMEs will reach up to 4.7 billion or 56% of world’s population in absolute
terms.
 According to the report by “Energy Outlook 2035”, India and China alone will be
responsible for the half of increase in energy demand by 2035.This will further rise till
2050.
Trends Analysis and Business Opportunities in BRIC Economies (till 2050)
Finnacle Investments
January, 2015
9
Working Women
 World scenario is changing in terms of employment. Female employment has grown to
66% in 2012 comparing to 58% in 1983 in UK. Thus, household chores will transform
evenly. Similar is the case with the EMEs .Moreover, marriage rate is falling. For
example in UK, marriage rate dropped to 5 in 1,000 to 7 people in 1000 over the last
30 years. This will further fall in coming 30 years. Single person household will
show the growth of up to 47.1 million worldwide (2012-20 scenarios). Thus the
scenario will rise further in coming years.
 The shift to nuclear families that started in west has started in EMEs. Thus, in 40s and
50s younger men has to manage the household work themselves.
Thus, huge transformation in the trends in BRIC countries provides new opportunities to do
businesses.
JYOTI GUPTA
PGDM 2014-16
IMT GHAZIABAD
Finnacle Investments
January, 2015
10
Editorial Team
Anshu Mishra
Neha Kumar
Jyoti Gupta

More Related Content

What's hot

IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...
IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...
IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...Katalyst Wealth
 
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report Katalyst Wealth
 
Aarti Drugs report Final
Aarti Drugs report FinalAarti Drugs report Final
Aarti Drugs report FinalJainis Chheda
 
Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18HEMAS HOLDINGS PLC
 
Sharekhan IPO note on Healthcare Global Enterprises
Sharekhan IPO note on Healthcare Global EnterprisesSharekhan IPO note on Healthcare Global Enterprises
Sharekhan IPO note on Healthcare Global EnterprisesPooja_Singh1732
 
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha Stock
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha StockDFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha Stock
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha StockKatalyst Wealth
 
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report AnkurShah108
 
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...Katalyst Wealth
 
Itc ltd (update) new
Itc ltd (update)   newItc ltd (update)   new
Itc ltd (update) newAnkurShah108
 
Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18HEMAS HOLDINGS PLC
 
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendation
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendationCera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendation
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendationKatalyst Wealth
 
Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17HEMAS HOLDINGS PLC
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationJigar Savla
 
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yFirstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yIndiaNotes.com
 
Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14HEMAS HOLDINGS PLC
 
Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19HEMAS HOLDINGS PLC
 
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendation
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendationSymphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendation
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendationKatalyst Wealth
 
Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13HEMAS HOLDINGS PLC
 

What's hot (20)

IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...
IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...
IPCA Laboratories ltd (NSE Code IPCALAB) - Nov'12 Katalyst Wealth Alpha recom...
 
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report
Aarti Drugs Ltd - Sep'18 Katalyst Wealth Alpha Report
 
Japfa Ltd (SGX: UD2)
Japfa Ltd (SGX: UD2)Japfa Ltd (SGX: UD2)
Japfa Ltd (SGX: UD2)
 
Aarti Drugs report Final
Aarti Drugs report FinalAarti Drugs report Final
Aarti Drugs report Final
 
Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18
 
Sharekhan IPO note on Healthcare Global Enterprises
Sharekhan IPO note on Healthcare Global EnterprisesSharekhan IPO note on Healthcare Global Enterprises
Sharekhan IPO note on Healthcare Global Enterprises
 
Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)
 
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha Stock
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha StockDFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha Stock
DFM Foods (BSE Code 519588) - Apr15 Katalyst Wealth Alpha Stock
 
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report
Rudra Shares Huhtamaki PPL Ltd.- Short Term Call Research Report
 
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
 
Itc ltd (update) new
Itc ltd (update)   newItc ltd (update)   new
Itc ltd (update) new
 
Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18
 
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendation
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendationCera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendation
Cera Sanitaryware ltd (NSE code CERA) - Katalyst Wealth alpha recommendation
 
Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 Presentation
 
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yFirstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
 
Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14Hemas Holdings PLC Investor Presentation Q3, 2013/14
Hemas Holdings PLC Investor Presentation Q3, 2013/14
 
Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19
 
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendation
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendationSymphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendation
Symphony Ltd (NSE - SYMPHONY) - Nov'13 Katalyst Wealth Alpha recommendation
 
Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13Hemas Investor Presentation 2012/13
Hemas Investor Presentation 2012/13
 

Viewers also liked

Viewers also liked (6)

Instructional leadership workshop Session 1
Instructional leadership workshop   Session 1Instructional leadership workshop   Session 1
Instructional leadership workshop Session 1
 
SMi Group's 3rd annual ISR conference
SMi Group's 3rd annual ISR conferenceSMi Group's 3rd annual ISR conference
SMi Group's 3rd annual ISR conference
 
MCFA Presentation
MCFA PresentationMCFA Presentation
MCFA Presentation
 
Shared Sandwich Project
Shared Sandwich ProjectShared Sandwich Project
Shared Sandwich Project
 
All about me xxx (2)
All about me xxx (2)All about me xxx (2)
All about me xxx (2)
 
European Crowdfunding Framework
European Crowdfunding FrameworkEuropean Crowdfunding Framework
European Crowdfunding Framework
 

Similar to Finnacle Investments Monthly Report Highlights Key News and Analysis

Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Alkesh Parihar
 
Impact of covid 19 on indian stock market
Impact of covid 19  on indian stock marketImpact of covid 19  on indian stock market
Impact of covid 19 on indian stock marketBhagavathManickavasa
 
Cipla 07092021 1630988705
Cipla 07092021 1630988705Cipla 07092021 1630988705
Cipla 07092021 1630988705robertbrookes6
 
Stocks for Investment.pdf
Stocks for Investment.pdfStocks for Investment.pdf
Stocks for Investment.pdfChauhanAman2
 
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016nik18031991
 
Study On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesStudy On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesVarsha Chauhan
 
Research Report on Abbott India Ltd.
Research Report on Abbott India Ltd.Research Report on Abbott India Ltd.
Research Report on Abbott India Ltd.Aditya Arora
 
Milwaukee Growth Fund-February Client Meeting Materials
Milwaukee Growth Fund-February Client Meeting MaterialsMilwaukee Growth Fund-February Client Meeting Materials
Milwaukee Growth Fund-February Client Meeting MaterialsAlexander D. Sagal
 
Cipla Limited Initiating Coverage - Natverlal Research
Cipla Limited Initiating Coverage - Natverlal ResearchCipla Limited Initiating Coverage - Natverlal Research
Cipla Limited Initiating Coverage - Natverlal ResearchGaurav Singh
 
Impact of covid on selected sectors of indian stock market
Impact of covid on selected sectors of indian stock marketImpact of covid on selected sectors of indian stock market
Impact of covid on selected sectors of indian stock marketArjunNair91
 
Equity Research Report on FMCG sector
Equity Research Report on FMCG sectorEquity Research Report on FMCG sector
Equity Research Report on FMCG sectorNirransh Jain
 

Similar to Finnacle Investments Monthly Report Highlights Key News and Analysis (20)

Weelynewsletter
WeelynewsletterWeelynewsletter
Weelynewsletter
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)
 
Weekly newsletter
Weekly newsletterWeekly newsletter
Weekly newsletter
 
Impact of covid 19 on indian stock market
Impact of covid 19  on indian stock marketImpact of covid 19  on indian stock market
Impact of covid 19 on indian stock market
 
Cipla 07092021 1630988705
Cipla 07092021 1630988705Cipla 07092021 1630988705
Cipla 07092021 1630988705
 
Ashika App Document.pdf
Ashika App Document.pdfAshika App Document.pdf
Ashika App Document.pdf
 
Envp cadila healthcare case
Envp cadila healthcare caseEnvp cadila healthcare case
Envp cadila healthcare case
 
Stocks for Investment.pdf
Stocks for Investment.pdfStocks for Investment.pdf
Stocks for Investment.pdf
 
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016
BP Equities_Granules India Ltd_Initiating Coverage_BUY_Trgt 179_27th Apr 2016
 
Study On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesStudy On Pharmaceuticals Companies
Study On Pharmaceuticals Companies
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Research Report on Abbott India Ltd.
Research Report on Abbott India Ltd.Research Report on Abbott India Ltd.
Research Report on Abbott India Ltd.
 
Daily equity report
Daily equity reportDaily equity report
Daily equity report
 
Milwaukee Growth Fund-February Client Meeting Materials
Milwaukee Growth Fund-February Client Meeting MaterialsMilwaukee Growth Fund-February Client Meeting Materials
Milwaukee Growth Fund-February Client Meeting Materials
 
Cipla Limited Initiating Coverage - Natverlal Research
Cipla Limited Initiating Coverage - Natverlal ResearchCipla Limited Initiating Coverage - Natverlal Research
Cipla Limited Initiating Coverage - Natverlal Research
 
Impact of covid on selected sectors of indian stock market
Impact of covid on selected sectors of indian stock marketImpact of covid on selected sectors of indian stock market
Impact of covid on selected sectors of indian stock market
 
Equity Research Report on FMCG sector
Equity Research Report on FMCG sectorEquity Research Report on FMCG sector
Equity Research Report on FMCG sector
 

More from Arpita0306

Sector updates for the week ending 22nd Feb 2015
Sector updates for the week ending 22nd Feb 2015Sector updates for the week ending 22nd Feb 2015
Sector updates for the week ending 22nd Feb 2015Arpita0306
 
Sector updates 25.1.2015
Sector updates 25.1.2015Sector updates 25.1.2015
Sector updates 25.1.2015Arpita0306
 
Sector updates 06.1.2015
Sector updates 06.1.2015Sector updates 06.1.2015
Sector updates 06.1.2015Arpita0306
 
Sector updates for the week ending 22nd Nov'14
Sector updates for the week ending 22nd Nov'14Sector updates for the week ending 22nd Nov'14
Sector updates for the week ending 22nd Nov'14Arpita0306
 
Sector updates for the week ending 7th Nov'14
Sector updates for the week ending 7th Nov'14Sector updates for the week ending 7th Nov'14
Sector updates for the week ending 7th Nov'14Arpita0306
 
Sector updates for the week ending 31st Oct'14
Sector updates for the week ending 31st Oct'14Sector updates for the week ending 31st Oct'14
Sector updates for the week ending 31st Oct'14Arpita0306
 
Sector Updates for week - 3rd to 9th Nov'14
Sector Updates for week - 3rd to 9th Nov'14Sector Updates for week - 3rd to 9th Nov'14
Sector Updates for week - 3rd to 9th Nov'14Arpita0306
 

More from Arpita0306 (7)

Sector updates for the week ending 22nd Feb 2015
Sector updates for the week ending 22nd Feb 2015Sector updates for the week ending 22nd Feb 2015
Sector updates for the week ending 22nd Feb 2015
 
Sector updates 25.1.2015
Sector updates 25.1.2015Sector updates 25.1.2015
Sector updates 25.1.2015
 
Sector updates 06.1.2015
Sector updates 06.1.2015Sector updates 06.1.2015
Sector updates 06.1.2015
 
Sector updates for the week ending 22nd Nov'14
Sector updates for the week ending 22nd Nov'14Sector updates for the week ending 22nd Nov'14
Sector updates for the week ending 22nd Nov'14
 
Sector updates for the week ending 7th Nov'14
Sector updates for the week ending 7th Nov'14Sector updates for the week ending 7th Nov'14
Sector updates for the week ending 7th Nov'14
 
Sector updates for the week ending 31st Oct'14
Sector updates for the week ending 31st Oct'14Sector updates for the week ending 31st Oct'14
Sector updates for the week ending 31st Oct'14
 
Sector Updates for week - 3rd to 9th Nov'14
Sector Updates for week - 3rd to 9th Nov'14Sector Updates for week - 3rd to 9th Nov'14
Sector Updates for week - 3rd to 9th Nov'14
 

Recently uploaded

Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 

Recently uploaded (20)

Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 

Finnacle Investments Monthly Report Highlights Key News and Analysis

  • 1. Finnacle Investments January, 2015 1 Finnacle Investments In this Issue: Monthly Portfolio Analysis Stock Recommendation: ALEMBIC PHARMACEUTICALS LTD Investor Watch: Bill Ackman What's Hot? (News and happenings) Deal Watch Technical trading term of the day: Head and Shoulders Article: Trends Analysis and Business Opportunities in BRIC Economies Return Plus + (Investments, portfolio and much more) Banking 26% Technology 13% Oil and Gas 8% Automotive 15% Pharmaceuticals 13% Engineering 14% Media & Entertainment 8% Others 3% Portfolio Allocation as on 31st Dec 2014 Stock Buy Price (INR) Sell Price (INR) Holding Period Return Infosys 1930 2100 8.81% Yes Bank 598 763.2 27.63% PVR 612 685 11.93% HCL Technologies 1500 1665.4 11.03% Akzo Nobel 1320 1450 9.85% MONTHLY PORTFOLIO ANALYSIS
  • 2. Finnacle Investments January, 2015 2  Alembic Pharma is a leader in several sub-segments of anti-infective therapeutic segment. In the last two to three years the company has invested heavily in increasing revenue from chronic therapies and regulated markets, which are high margin businesses.  The company continues to improve its year-on-year margins year after year with an EBITDA margin of 19% by the end of FY14. This is expected to grow by 100-125 bps annually and reach 23-24% over next 3-4 years owing to growing international generic business on account of: annual launches of 7-9 products in the US market including complex generics and many high value launches, market share improvement in existing products in US, ramp up in European generic portfolio where the company is expected to be the generic for a niche product.  The company is expected to go live with its own front end in US in FY16 which will assist in gaining higher market share in the new launches and ramp up existing products that the company has launched through front end partners.  Alembic Pharma has final ANDA (Abbreviated New Drug Application) approvals for 31 products out of which it has commercialized 25 products and is expected to launch some of the products once it has its own front end. Parameter Value(INR) 52-Week High 493.90 (12-Jan-2015) 52-Week Low 211.25 (27-Jan-2014) Current Market Price 477.85 (25-Jan-2015) STOCK RECOMMENDATION: ALEMBIC PHARMACEUTICALS LTD FUNDAMENTALS
  • 3. Finnacle Investments January, 2015 3  Domestic formulation is expected to grow by 16-18% annually on account of around 25 new launches in specialty segment while international brands (ROW – 3% of sales) are expected to grow by 25-30% on account of low base and commercialization of products in new markets like South East Asia, CIS, brazil, East Africa where company has made filings over last 2 years. 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 Revenue EBITDA PAT 14,679 2,194 1,301 15,260 2,520 1,652 18,684 3,577 2,355 Revenue, EBITDA, PAT (in INR million) FY12 FY13 FY14 FINANCIAL SNAPSHOT
  • 4. Finnacle Investments January, 2015 4 Founder, Pershing Square Capital Management Ackman got his start in the real estate business, where he worked for his father prior to starting Gotham. Bill Ackman is an activist investor. He buys the common stocks of public companies, and pushes for changes so that the market can realize the value of the companies. Ackman buys stocks trading at a discount, and sells when the companies reach their appraised value. His firm performed incredibly in 2014. In the first six months of the year, the flagship hedge fund returned 25% after fees. The portfolio includes new investment in Allergan, which drive performance. Ackman helped back Valeant Pharmaceuticals' hostile takeover of Allergan by taking a position in the target company before the effort was made public, benefiting from the surge in Allergan's stock. In 2014, Ackman has also seen his huge bet against Herbalife go his way as shares of the company fell. Ackman continues to be one of the most prominent activist investors, managing some $15 billion and working to raise billions of dollars more in permanent capital. INVESTOR WATCH: Bill Ackman Net Worth: US$1.69 billion (as on November 2014) Source of Wealth: Hedge funds, Self-Made Age: 48 Education: Bachelor of Arts / Science, Harvard University; Master of Business Administration, Harvard University Residence: New York
  • 5. Finnacle Investments January, 2015 5 RBI’s surprise rate cut The Reserve Bank of India (RBI) surprised markets with a 25 basis point reduction in repo rates on Thursday, 15 Jan bringing it to 7.75% the Cash reserve ratio is however remains unchanged to 4%. The main reason for rate cut is to ease inflationary pressures and to achieve fiscal deficit target. This move of RBI will boost investor sentiments and will have positive impact on capital intensive industry like Auto and Auto Ancillary Sector, Real Estate and Infrastructure sector and Banking and NBFC sector. TCS ends RIL's 23-year run as most profitable firm Tata Consultancy Services (TCS) has overtaken Reliance Industries Ltd (RIL) to become the country's most profitable private company on a quarterly basis. RIL has been topping the profitability charts since 1992-93, when it went past Tata Steel in the rankings. TCS posted a profit of Rs 5328 crore for the quarter ended December where reliance profit dipped to Rs 5256 crore due to falling crude oil prices. Airtel, Idea, RComm & Vodafone may collectively bid Rs 74,000 crore for 900 Hz spectrum Airtel, Idea, RComm & Vodafone may collectively bid Rs 74,000 crore for spectrum as these companies are expected to prioritize 900 MHz airwave renewals over boosting their 3G . The operators are likely to factor in existing debt, incremental capex needs for data business and fallback cash reserves to acquire super-efficient 4G airwaves in the 700 MHz band in the near future spectrum holdings. Novartis AG and GlaxoSmithKline to create a global healthcare joint venture Novartis India is selling its OTC division to GlaxoSmithKline, Consumer Private Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore. The transfer of the business is subject to the receipt of all applicable legal and regulatory approvals, consents, permissions and sanctions as may be necessary from concerned authorities. Drop in the crude oil by 60% since Jan 2014 Crude oil prices have fallen down to its lowest level of five and a half years. This drop has been due to increase in the production of US shale oil and decrease in demand by Europe and Asia. As per the Goldman Sachs, WTI will be trading at $41 a barrel and Brent at $42 in three months and they also believe prices will stay lower for longer. In order to re-balance the global market the investment in shale has to be curtailed. Societal General has reduced their average WTI price to $51a barrel for this year and Brent will average around $55 a barrel. With the supply staying at its own place and the demand going weak, the oil prices will keep going down. What's Hot? (News and Happenings)
  • 6. Finnacle Investments January, 2015 6 Apollo Health acquires Nova Specialty Hospital for Rs. 145 crore In a strategic move aimed at expansion, Apollo Health and Lifestyle, a wholly owned subsidiary of Apollo Hospitals Group has acquired Nova Specialty Hospital in a Rs. 145 crore deal. Nova is currently present in 8 cities including Mumbai, Jaipur and Kanpur. The existing Nova centers will function under the Apollo brand name. Apollo Hospital is looking for a business of Rs.500 crore in a span of 5 years in multi-specialty short stay/day surgery centers, while the combined network is expected to clock a turnover between Rs 115 crore - 125 crore for the year ending in Mar'15 and reach break even in the next 18-24 months. Reliance Capital all set to exit Yatra.com with a 12-fold gain by sale of its 16% stake Reliance Capital is all set to sell its 16% stake in the online travel portal Yatra.com for Rs 500 crore, a 12-times appreciation since investment of Rs. 40 crore in 2006. The move to exit Yatra.com cashes in on the booming e-commerce industry and is in sync with the Reliance Group's recently announced plans to focus on core business and encashing its minority investments. The company is in talks with 2-3 international investors and expects to close the deal in 4-6 weeks. Zomato buys Italian restaurant search guide, its fifth deal on the global front in recent months In what would be its fifth buy in the recent months, Zomato Media Private Limited has bought an Italian restaurant search guide, Cibando for an undisclosed amount. With this, the company has expanded its presence to 20 countries. The company appears to be on a global acquisition spree with plans to enter the US market through acquisition of market leaders and building global payment systems for the diners. Here's a look at Zomato's recent buys: Company Country Amount Gastronauci Poland Undisclosed Lunchtime.cz Czech Republic $2.2 million Obedovat.sk Slovakia $1 million MenuMania New Zealand Undisclosed American Tower Corporation to Pick up Majority Stake in Viom Networks American Tower Corporation is soon going to acquire 51% stake in Viom networks, the second largest tower company in India, in a deal that is estimated to be around $ 1 billion. In the first phase, Srei Infrastructure, which currently holds 18.5% stake would exit the venture while Tata's current stake of 55% would be trimmed down to 26-30% and would become a minority DEAL WATCH
  • 7. Finnacle Investments January, 2015 7 shareholder along with Macquarie Fund, SBI, GIC, Oman Investment Fund and IDFC. The second phase of the deal involves merger of Viom with the Indian entity of the ATC which currently owns 12,000 towers in the country. The merged entity would be looking at a public offering through which Tatas would seek a complete exit. Viom owns around 42,000 towers in the country and counts Tata Teleservices as one of its major clients bringing in over 40% of the revenues. ATC recently acquired 4,800 communication towers from Bharti Airtel for $1.05 billion. Head and Shoulders pattern is basically identified when the security prices cover all of the following characteristics: 1. Price first falls to a trough and then make a rise 2. Price again fall below the former trough 3. It makes a rise again. 4. Finally, after this price falls again, but not as far as second trough. 5. Once the final trough, price heads upward towards the resistance level. INVESTOR DECISION: Investor takes a long position when price rises above the resistance of the neckline. First and third troughs are called as shoulder (as shown in figure) and second peak is the head. We also have inverse Head and Shoulders pattern. TECHNICAL TRADING TERM OF THE MONTH - HEAD AND SHOULDERS
  • 8. Finnacle Investments January, 2015 8 Ageing World  World is taking a transition in demographics. Population is getting older due to a combination of longer life expectancy especially in developed markets and decline in birth rates. Euro-monitor report reveals that in 2012, 577 million people were in the age category of 65+. This will rise to 775 million people in 2020 and will further rise to 35% in 2050 (keeping in mind current trends).  Though the demographic shift is more prevalent in developed market- Western Europe’s median age population is 40, while the global median age is 30. Few emerging markets like India and China will have significant elderly consumers. Technology: Niche Opportunities  One of the game changer points is rise in ownership of technology. Like in 2001, average spending on computers was US $ 22 in Western Europe and at US $17 in North America. Now, it has risen to US $ 77 in Western Europe and US $ 73 in North America.  Technology aimed at formation of cleaning products that are less likely to use water and other fossil fuel. The innovations are likely to be game changer in home care. Income level  In BRIC mega-cities, exponential economic growth, improvement in living standards and higher consumer spending will lead to intense competition and market saturation. The rising disposable income in second tier cities will lead to accessibility of Western brands. Though smaller in size, BRIC cities have projected to rise up 30-50% in next decades. Energy efficiency preference  For energy exporters like Saudi Arabia, UAE; energy affordability and security was never been the major concern. However, these countries still suffer from impact on the environment from energy production. For emerging market economies diversification of energy mix has always been the cause of concern. These countries rely on fossils for the electricity production. Economic growth and population will raise the demand for energy in these EMEs.  In all these 25 economies, aggregate population will expand by around 12.7% during 2014-30 and this will further rise by approximately 10% in 50s. Till 2030, population in these EMEs will reach up to 4.7 billion or 56% of world’s population in absolute terms.  According to the report by “Energy Outlook 2035”, India and China alone will be responsible for the half of increase in energy demand by 2035.This will further rise till 2050. Trends Analysis and Business Opportunities in BRIC Economies (till 2050)
  • 9. Finnacle Investments January, 2015 9 Working Women  World scenario is changing in terms of employment. Female employment has grown to 66% in 2012 comparing to 58% in 1983 in UK. Thus, household chores will transform evenly. Similar is the case with the EMEs .Moreover, marriage rate is falling. For example in UK, marriage rate dropped to 5 in 1,000 to 7 people in 1000 over the last 30 years. This will further fall in coming 30 years. Single person household will show the growth of up to 47.1 million worldwide (2012-20 scenarios). Thus the scenario will rise further in coming years.  The shift to nuclear families that started in west has started in EMEs. Thus, in 40s and 50s younger men has to manage the household work themselves. Thus, huge transformation in the trends in BRIC countries provides new opportunities to do businesses. JYOTI GUPTA PGDM 2014-16 IMT GHAZIABAD
  • 10. Finnacle Investments January, 2015 10 Editorial Team Anshu Mishra Neha Kumar Jyoti Gupta